QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-maintains-buy-on-valens-semiconductor-lowers-price-target-to-3

Needham analyst Quinn Bolton maintains Valens Semiconductor (NYSE:VLN) with a Buy and lowers the price target from $4 to $3.

 valens-semiconductor-lowers-fy2025-sales-guidance-from-71000m-76000m-to-69400m-70100m-vs-67820m-est

Valens Semiconductor (NYSE:VLN) lowers FY2025 sales outlook from $71.000 million-$76.000 million to $69.400 million-$70.100 mil...

 valens-semiconductor-sees-q4-sales-18200m-18900m-vs-18525m-est

Valens Semiconductor (NYSE:VLN) sees Q4 sales of $18.200 million-$18.900 million vs $18.525 million analyst estimate.

 valens-semiconductor-q3-adj-eps-004-beats-007-estimate-sales-17335m-beat-15400m-estimate

Valens Semiconductor (NYSE:VLN) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0...

Core News & Articles

Valens Semiconductor (NYSE:VLN) today announced that Samsung is supporting the MIPI A-PHY standard for high-speed sensor connec...

 valens-semiconductor-sees-q3-sales-15100m-15600m-vs-17425m-est

Valens Semiconductor (NYSE:VLN) sees Q3 sales of $15.100 million-$15.600 million vs $17.425 million analyst estimate.

 valens-semiconductor-q2-adj-eps-004-misses-003-estimate-sales-17059m-beat-16700m-estimate

Valens Semiconductor (NYSE:VLN) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $...

 needham-reiterates-buy-on-valens-semiconductor-maintains-4-price-target

Needham analyst Quinn Bolton reiterates Valens Semiconductor (NYSE:VLN) with a Buy and maintains $4 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION